ArticleMolecular therapy. Methods & clinical development2025

AAV hamartin gene therapy in a stochastic, cerebral mouse model of tuberous sclerosis type 1.

Edwina Abou Haidar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.